- Price is above Fair Value, showing premium demand versus the model.
ANURAS
NSI
Week ended 07 Aug 2026
Weekly Investor Report
Anupam Rasayan India Ltd · Basic Materials · Specialty Chemicals
Latest close
1,215 INR
0.6%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -5.3% below the Trend Line and sits at 45.8% of its 52-week range. The latest completed week returned 0.6%, after a -4.2% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is expensive relative to peers. The latest news-sentiment score is 51/100. Near-term considerations: volume confirmation is below normal.
Setup score
40
out of 100
Latest Close
1,215 INR
7 Aug 2026
1W Return
0.6%
latest completed week
4W Return
-4.2%
short-term follow-through
12W Return
-11.7%
quarterly tape
Trend Breadth
84.6%
44 of 52 weeks active
Volume Ratio
0.8x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Activity pressure is negative, which weakens the current setup.
- Next-week expectancy is negative at 41.64% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
0.6%
Latest completed week; four-week move -4.2%.
Indicator stack
47/24
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 41.64%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
51/100
25 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -5.3% below the Trend Line and sits at 45.8% of its 52-week range. The latest completed week returned 0.6%, after a -4.2% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.8x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.3912-week average 0.67
12-week confirmation
Trend active4/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure4/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership10/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.39Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers11 reversal markers
No recent accumulation markers. 1 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -4.2% over four weeks, -11.7% over 12 weeks, and 8.4% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year44
Trend breadth84.6%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-1.20Latest activity-pressure read.
Pressure change-56.7%Four-week change in activity pressure.
Leadership-1.12Latest relative-leadership reading.
RS change-120.2%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is expensive relative to peers.
Factor week 09 Aug 2026
Financial statements through 31 Dec 2025
Field coverage 91%
Model confidence 72%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength10/100Blend of value, momentum, and quality. Underlying universe rank 91; rank 1 is best.
Value14/100Relative valuation strength. Underlying universe rank 87; rank 1 is best.
Quality11/100Profitability and accounting quality. Underlying universe rank 90; rank 1 is best.
Momentum73/100Medium-term price momentum. Underlying universe rank 28; rank 1 is best.
Growth7/100Revenue and earnings growth. Underlying universe rank 94; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework19/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 88.7x Price divided by trailing earnings.
- Price / sales
- 7.5x Market value relative to trailing revenue.
- EV / EBITDA
- 29.5x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- -2.9% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 37.4% Gross profit retained from each unit of revenue.
- Operating margin
- 21.3% Operating profit retained from revenue.
- Free-cash-flow margin
- -23.8% Free cash flow generated from revenue.
- Return on invested capital
- 7.2% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- -2.8% Latest one-year revenue growth.
- EPS growth
- -27.5% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- - Latest one-year free-cash-flow growth.
- Piotroski F-score
- 3/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 0.1% Cash dividends relative to market value.
- Buyback yield
- -0.0% Net share repurchases relative to market value.
- Shareholder yield
- 0.1% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 2.4x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment51/100
Weighted news tone is neutral across 25 relevant articles.
2 positive · 23 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-14.2%Distance below the 52-week high.
13-week volatility2.4%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher13 of 2613 weeks finished lower.
Best week+4.1%Week of 24 Apr.
Worst week-5.9%Week of 12 Jun.
Latest week+0.6%Week of 7 Aug.
Shape of recent returns
Strong gains1
Modest gains12
Flat weeks0
Modest losses11
Sharp losses2
Recent vol2.4%13-week weekly-return volatility.
Base vol3.4%52-week weekly-return volatility.
Up/down split26/26Count of positive and negative weeks in the 52-week window.
Average skew2.5% / -2.1%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIN Basic Materials
4-week rank93 / 100
Group average2.8%
Trend breadth52.0%
Trend52.0%active weekly trend signals
MD52.0%positive activity pressure
RS63.0%positive relative leadership
Four-week leaders
IndustryIN Specialty Chemicals
4-week rank85 / 100
Group average5.8%
Trend breadth77.0%
Trend77.0%active weekly trend signals
MD75.0%positive activity pressure
RS72.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape41/100
Trend, activity pressure, participation, and risk combine to a 41/100 tape read.
Indicator analysis45/100Latest 12-week confirmation: trend 4/12, activity pressure 4/12, relative leadership 10/12.
Activity pressure 0.39; 1 reversal markers Next-Week ExpectancyNegative 41.64%Next-week expectancy is negative with a 41.64% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors24/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 73; Small Cap Core rank 86 SVQF19/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 1283.5 of 1576 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment51/100Weighted news tone is neutral across 25 relevant articles.
Anupam Rasayan India makes open offer for Bliss GVS Pharma stake Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 1,215 INR | 0.6% | 1,283 INR | 984.8 INR | -1.20 | -1.12 | 976.3K | Off |
| 31 Jul 2026 | 1,208 INR | -3.3% | 1,286 INR | 983.1 INR | -1.05 | -0.79 | 826.9K | Off |
| 24 Jul 2026 | 1,250 INR | -1.4% | 1,290 INR | 981.3 INR | -0.90 | 5.44 | 1.3M | Off |
| 17 Jul 2026 | 1,268 INR | -0.0% | 1,292 INR | 979.6 INR | -0.78 | 4.72 | 4.4M | Off |
| 10 Jul 2026 | 1,268 INR | -0.1% | 1,294 INR | 977.7 INR | -0.76 | 5.56 | 1.4M | Off |
| 3 Jul 2026 | 1,270 INR | -0.4% | 1,296 INR | 976.1 INR | -0.74 | 5.73 | 187.2K | Off |
| 26 Jun 2026 | 1,275 INR | -0.2% | 1,295 INR | 974.3 INR | -0.51 | 7.43 | 0 | Off |
| 19 Jun 2026 | 1,277 INR | 2.1% | 1,294 INR | 972.7 INR | -0.25 | 8.16 | 163.9K | Off |
| 12 Jun 2026 | 1,250 INR | -5.9% | 1,293 INR | 971.2 INR | 0.01 | 7.98 | 527.8K | On |
| 5 Jun 2026 | 1,328 INR | 2.7% | 1,287 INR | 970.1 INR | 0.39 | 16.32 | 217.2K | On |
| 29 May 2026 | 1,294 INR | -5.3% | 1,279 INR | 968.5 INR | 0.62 | 13.12 | 2.1M | On |
| 22 May 2026 | 1,366 INR | -0.7% | 1,271 INR | 967.4 INR | 0.68 | 19.25 | 1.2M | On |
| 15 May 2026 | 1,376 INR | 0.3% | 1,262 INR | 966.4 INR | 0.65 | 21.46 | 2.1M | On |
| 8 May 2026 | 1,372 INR | 2.1% | 1,252 INR | 965.2 INR | 0.29 | 19.42 | 2.8M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.